Everybody’s gunning for that gargantuan, multi-million-dollar, early retirement, 4x projected revenue exit that lands them softly on the deck of a yacht off Catalina Island. But early on, when the big sell-off is still miles away, capital raises from sale of equity depend less on your natural product company’s valuation than you might think. Ryan Caldbeck of crowdfunding platform CircleUp explains why.

Ryan Caldbeck, Founder and CEO

June 12, 2013

3 Min Read
3 reasons why valuation doesn’t matter for an equity raise

As CEO of CircleUp, an equity-based crowdfunding website focused on consumer, I often discuss valuations with CPG companies that want to be accepted on our platform to raise capital. More often than you may think, the company will be excited to join the platform, and we’ll be excited to have the company, but we’ll get hung up on one number—valuation.

CircleUp cannot give advice, so we end up having to pass on companies where valuation is just out of line with industry comparables. While I’d be remiss to say valuation does not matter if you are selling 80 or 100 percent of your business, when you are raising an initial round of capital and selling 5 to 25 percent of your equity, valuation matters a lot less than you think.

Time trumps valuation bumps

Why is that? First, when a small CPG company is raising its first round of capital, it's typically under $5 million in sales. Let's assume you have a $5 million CPG company looking to raise $2 million. You have offers to raise the money at a $10 million post-money valuation (i.e. you need to sell 20 percent of your equity). However, you have your heart set on selling only 15 percent of your company (i.e. a valuation of $13.3 million).

In the time it could take you to get the bump in valuation, which can often be 6 to 12 months, your competitors are out there executing and 100 percent focused on growing their business with the capital to do so. You, meanwhile, are spending countless hours taking meetings with potential investors and fulfilling data requests, all the while you are starved for the cash you need to grow at the juncture in time most critical to your growth. Not a great outcome.

But, let’s say you weigh the costs and benefits and decide that it's worth holding out for the higher valuation—I mean, we're talking an extra 33 percent! This brings me to the second reason valuation doesn't matter as much as you think.

Capital infusion sooner

Let's suppose you raise money at the $13.3 million valuation; however, your $5 million revenue business only grows to $7 million over the next five years. What are your exit options at this point, with a seven-year-old stagnant business? Very, very limited. Strategics and private equity firms want to buy brands with momentum and both will be reluctant to look at businesses with less than $10 million in sales.

However, on the flip side, if you’ve grown the business from $5 million to $50 million and sell it for a valuation of $75 million, your equity in the case of a $10 million valuation for that initial round is now worth $60 million vs. $63.75 million had you received the $13.3 million initial valuation. While $3.75 million isn’t anything to sneeze at, either way, you will be very, very wealthy in both cases. And as we discussed, the lower valuation probably made you more likely to succeed because you received a capital infusion sooner.

Equity partner quality

The final reason valuation doesn’t matter as much as you think is because when you are raising that initial round, the quality of your equity partner matters a lot more than owning a few more percentage points.

An equity partner is a lot like a spouse: they are someone to discuss your major decisions with, your strategic direction with, to celebrate the successes and to commiserate the failures. And exiting the partnership can be very painful and expensive. You don’t want to compromise on the quality and track record of your equity partner for an unproven partner who flashes a higher valuation—you might be happy now, but you’ll pay for it in more ways than one later.

About the Author(s)

Ryan Caldbeck

Founder and CEO

Ryan Caldbeck is the Founder and CEO of CircleUp (www.circleup.com), an equity-based investment platform focused on high-growth consumer and retail companies.

Ryan started CircleUp after a career of investing experience in consumer product and retail-focused private equity at TSG Consumer Partners and Encore Consumer Capital. As a Director at Encore, Ryan led a number of private investments and served on the Board of Zuke’s, The Isopure Company and Philly Swirl. His experience in private equity exposed him to many great consumer and retail businesses that were too small to obtain funding through the customary private equity channels. As a result, he decided to make funding available to these small and promising companies through CircleUp.

Ryan received his MBA from Stanford and a dual BA from Duke, where he was a member of the 2001 NCAA basketball National Championship team. He holds Series 24, 63, and 82 licenses. Ryan is also a frequent contributor to Forbes and The Huffington Post.

Subscribe and receive the latest updates on trends, data, events and more.
Join 57,000+ members of the natural products community.

You May Also Like